Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Yerly

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Lancet (London, England)|September 24, 1988
Hypohaptoglobinaemia as an epidemiological and clinical indicator for malaria. Results of two studies in a hyperendemic region in West AfricaA Rougemont, O Dumbo, M Bouvier, et al.
New Microbes and New Infections|June 18, 2015
Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and reviewN Wagner, C A Wyler-Lazarevic, S Yerly, et al.
New Microbes and New Infections|June 4, 2016
Corrigendum to "Dolutegravir-based antiretroviral therapy in a severely overweight child with a multi-drug resistant human immunodeficiency virus infection. A case report and review" [New Microbes New Infect] 6 (2015) 1-4]N Wagner, C A Wyler-Lazarevic, S Yerly, et al.
AIDS (London, England)|October 28, 1997
Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort StudyP Lorenzi, S Yerly, K Abderrakim, et al.
The Journal of Tropical Medicine and Hygiene|June 1, 1991
Comparative evaluation of an ELISA based on recombinant polypeptides and IFA for serology of malariaI K Srivastava, M Schmidt, M Grall, et al.
AIDS (London, England)|March 15, 2000
Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort StudyS Yerly, L Kaiser, T V Perneger, et al.
AIDS (London, England)|June 15, 2000
Clinical features of acute HIV-1 infection: zidovudine-resistant isolates compared with zidovudine-sensitive isolatesP Vanhems, R Gaudet, B Hirschel, et al.
HIV Medicine|November 19, 2011
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patientsA Calmy, M Bel, A Nguyen, et al.
Antiviral Therapy|March 21, 2000
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort StudyO T Rutschmann, M Opravil, A Iten, et al.
AIDS (London, England)|April 15, 1999
Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort StudyP Lorenzi, M Opravil, B Hirschel, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|September 24, 1988
Hypohaptoglobinaemia as an epidemiological and clinical indicator for malaria. Results of two studies in a hyperendemic region in West AfricaA Rougemont, O Dumbo, M Bouvier, et al.
New Microbes and New Infections|June 18, 2015
Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and reviewN Wagner, C A Wyler-Lazarevic, S Yerly, et al.
New Microbes and New Infections|June 4, 2016
Corrigendum to "Dolutegravir-based antiretroviral therapy in a severely overweight child with a multi-drug resistant human immunodeficiency virus infection. A case report and review" [New Microbes New Infect] 6 (2015) 1-4]N Wagner, C A Wyler-Lazarevic, S Yerly, et al.
AIDS (London, England)|October 28, 1997
Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort StudyP Lorenzi, S Yerly, K Abderrakim, et al.
The Journal of Tropical Medicine and Hygiene|June 1, 1991
Comparative evaluation of an ELISA based on recombinant polypeptides and IFA for serology of malariaI K Srivastava, M Schmidt, M Grall, et al.
AIDS (London, England)|March 15, 2000
Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort StudyS Yerly, L Kaiser, T V Perneger, et al.
AIDS (London, England)|June 15, 2000
Clinical features of acute HIV-1 infection: zidovudine-resistant isolates compared with zidovudine-sensitive isolatesP Vanhems, R Gaudet, B Hirschel, et al.
HIV Medicine|November 19, 2011
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patientsA Calmy, M Bel, A Nguyen, et al.
Antiviral Therapy|March 21, 2000
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort StudyO T Rutschmann, M Opravil, A Iten, et al.
AIDS (London, England)|April 15, 1999
Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort StudyP Lorenzi, M Opravil, B Hirschel, et al.
Pageof 9